A critical issue that impedes advances in public health is the chasm between what we know can improve health and what is implemented in everyday practice. In addition, to have the highest impact, diverse participants should be involved in all types of clinical and translational research, to ensure both the relevance of research findings to the general population and the likelihood that they can be disseminated to improve public health in a meaningful way. Finally, implementation of research findings requires that translational research occurs in an efficient and organized environment. All of these activities are critical to a learning health care system by providing the foundation for information feedback loops, team-based learning and investigation, stakeholder participation, opportunities for education, continuous improvement, and sustainability. The mission of the Wake Forest Translational Science Institute (TSI) is to provide an innovative, efficient, and sustainable research infrastructure to accelerate WF's transformation, and thus speed the translation of discoveries to improve health. The purpose of this Clinical and Translational Science Award (CTSA) application is to synergize the fundamental positive changes that the TSI has already brought to bear at Wake Forest Baptist Health. The TSI has already made substantive progress to develop and augment our translational workforce; provide outstanding support in biostatistics, epidemiology, and research design; and assure that our research complies with regulatory guidelines and meets ethical standards. Our rapidly growing Clinically Integrated Network will aggregate data from our affiliates to provide an extraordinarily rich source of clinical information to inform new research directions, facilitated by our biomedical informatics expertise. We can offer to the CTSA network our resources and expertise in building efficient clinical research support programs and extensive experience in the conduct of multi-center clinical research, especially studies focused on older adults, in which our track record is exemplary. The TSI also has model programs in community engagement, team science, and recruitment of special populations into translational research. We propose novel experimental approaches that will test methodologies to advance the science of translational science. In particular, we can offer our world-class capabilities to support the use of nonhuman primate models for research of high translational value to public health. With CTSA support, we can use this comprehensive infrastructure to fund new pilot projects and new multidisciplinary research teams, and offer innovative training to help those ventures succeed. Wake Forest Baptist Health is a fully integrated medical center in which governance, quality improvement, and research discoveries ? including the intellectual property that may result from those discoveries ? are highly aligned. In summary, the TSI is poised to be a productive hub within the CTSA network. Project Summary/Abstract Page 203 Contact PD/PI: Li, King C.

Public Health Relevance

The purpose of this Clinical and Translational Science Award (CTSA) application is to synergize the fundamental positive changes that the Translational Science Institute has already brought to bear at Wake Forest Baptist Health. The TSI has already made substantive progress to develop and augment our translational workforce to produce new scientific discoveries and higher-quality health care; provide outstanding support in biostatistics, epidemiology, and research design; and assure that our research complies with regulatory guidelines and meets ethical standards. We offer our innovative methods in these areas to the CTSA network, and particularly our outstanding expertise in clinical trial conduct (especially in older adults) and use of nonhuman primates in research of high relevance to human health. Project Narrative Page 204

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001420-03
Application #
9250828
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Brooks, Pj
Project Start
2015-08-13
Project End
2019-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
3
Fiscal Year
2017
Total Cost
$3,028,705
Indirect Cost
$792,816
Name
Wake Forest University Health Sciences
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Bhatt, Nikunj B; Pandya, Darpan N; Rideout-Danner, Stephanie et al. (2018) A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant 89Zr-immuno-PET agents. Dalton Trans 47:13214-13221
Greenland, Philip; Blaha, Michael J; Budoff, Matthew J et al. (2018) Coronary Calcium Score and Cardiovascular Risk. J Am Coll Cardiol 72:434-447
Church, Rachel J; Kullak-Ublick, Gerd A; Aubrecht, Jiri et al. (2018) Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology :
Nagpal, Ravinder; Wang, Shaohua; Ahmadi, Shokouh et al. (2018) Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Sci Rep 8:12649
Emdin, Connor A; Khera, Amit V; Chaffin, Mark et al. (2018) Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease. Nat Commun 9:1613
Cuffe, Helen; Liu, Mingxia; Key, Chia-Chi C et al. (2018) Targeted Deletion of Adipocyte Abca1 (ATP-Binding Cassette Transporter A1) Impairs Diet-Induced Obesity. Arterioscler Thromb Vasc Biol 38:733-743
Gronlund, Carina J; Sheppard, Lianne; Adar, Sara D et al. (2018) Vulnerability to the Cardiovascular Effects of Ambient Heat in Six US Cities: Results from the Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology 29:756-764
Miller Jr, David P; Denizard-Thompson, Nancy; Weaver, Kathryn E et al. (2018) Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial. Ann Intern Med 168:550-557
Bhambhani, Vijeta; Kizer, Jorge R; Lima, Joao A C et al. (2018) Predictors and outcomes of heart failure with mid-range ejection fraction. Eur J Heart Fail 20:651-659
Haykowsky, Mark J; Nicklas, Barbara J; Brubaker, Peter H et al. (2018) Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction. JACC Heart Fail 6:640-649

Showing the most recent 10 out of 241 publications